The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of inhibition of receptor tyrosine kinase AXL by a selective small molecular inhibitor R428 (BGB321) on DNA damage repair response in ovarian cancer cells.
 
Ruby Yun-Ju Huang
Employment - ACT Genomics (I); Ferring (I)
Leadership - ACT Genomics (I)
Stock and Other Ownership Interests - ACT Genomics (I)
Honoraria - AstraZeneca
Consulting or Advisory Role - Roche (I)
Travel, Accommodations, Expenses - AstraZeneca
 
Xun Hui Yeo
No Relationships to Disclose
 
Wai Leong Tam
No Relationships to Disclose